QQ客服 官方微博 反馈留言

	Multi-centre randomized controlled study comparing adjuvant vs neo-adjuvant chemotherapy with docetaxel plus carboplatin in resectable stage IB to IIIA NSCLC: final results of CSLC0501
	Wu, Y-L.[1,2]; Yang, X-N.[1,2]; Zhong, W.[1,2]; Ben, X.[1,2]; Qiao, G-B.[3]; Wang, Q.[4]; Wang, C.[5]; Luo, H-H.[6]; Wang, Z.[7]; Yan, H-H.[1,2]
	2016
卷号	27
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4461692
专题	暨南大学
作者单位	1.[1]Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China 2.[2]Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China 3.[3]Guangzhou Mil Command, Thorac Surg, Thorac Surg, Guangzhou, Guangdong, Peoples R China 4.[4]Fudan Univ, Zhongshan Hosp, Thorac Surg, Shanghai, Peoples R China 5.[5]Tianjin Med Univ, Thorac Surg, Gen Hosp, Tianjin, Peoples R China 6.[6]Sun Yat Sen Univ, Thorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 7.[7]Jinan Univ, Shenzhen Peoples Hosp, Thorac Surg, Shenzhen, Peoples R China
推荐引用方式 GB/T 7714	Wu, Y-L.[1,2],Yang, X-N.[1,2],Zhong, W.[1,2],et al. Multi-centre randomized controlled study comparing adjuvant vs neo-adjuvant chemotherapy with docetaxel plus carboplatin in resectable stage IB to IIIA NSCLC: final results of CSLC0501[J],2016,27.
APA	Wu, Y-L.[1,2].,Yang, X-N.[1,2].,Zhong, W.[1,2].,Ben, X.[1,2].,Qiao, G-B.[3].,...&Yan, H-H.[1,2].(2016).Multi-centre randomized controlled study comparing adjuvant vs neo-adjuvant chemotherapy with docetaxel plus carboplatin in resectable stage IB to IIIA NSCLC: final results of CSLC0501.,27.
MLA	Wu, Y-L.[1,2],et al."Multi-centre randomized controlled study comparing adjuvant vs neo-adjuvant chemotherapy with docetaxel plus carboplatin in resectable stage IB to IIIA NSCLC: final results of CSLC0501".27(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。